This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
05 Feb 2021  |  North America  |  Mega Trends
Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market
Early-stage R&D and Commercial Applications Fuel the Growth Pipeline
The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...
$4,950.00 -
03 Feb 2021  |  North America  |  Mega Trends
Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market
Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...
$4,950.00 -
03 Sep 2019  |  North America  |  Market Research
Global Single Cell Genomics and Proteomics Market, Forecast to 2023
Clinical Applications for Single Cell Analysis Remain a Heavily Uncontested Market Place
Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. Th...
$1,500.00 -
30 Dec 2013  |  Europe  |  Technology Research
The Untapped Potential in Live Cell Imaging (Technical Insights)
Improved cellular dynamics in disease diagnostic and drug discovery.
The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented...
$4,950.00 -
27 Dec 2013  |  Global  |  Technology Research
Emerging Technologies in Infectious Diseases Diagnostics (Technical Insights)
Infectious diseases diagnostics for the developing world
This research service focuses on the emerging diagnostic technologies (for TB, HIV, HCV, HPV), the developmental initiatives, corporate developments by market leaders, and the role of international organizations within this market. It enlists end-user demands. The research service discusses the existing healthcare structure within the developing re...
$4,950.00 -
26 Dec 2013  |  Global  |  Technology Research
Technology Breakthroughs in Aesthetic Procedures (Technical Insights)
Advancements in laser technology to significantly increase non-invasive aesthetic procedures.
Aesthetic procedures though cost intensive in nature, has experienced increased growth over the past decade. Companies have and are coming up in this space with all-inclusive vacation cum procedure packages which are alluring patients to undergo such procedures. Since such procedures are not covered by health insurance, price is the major selling...
$4,950.00 -
19 Dec 2013  |  Global  |  Market Research
Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market
Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
$2,450.00 -
12 Dec 2013  |  Latin America  |  Market Research
Analysis of the Brazilian Market for Reagent Kits in In Vitro Diagnosis
Healthcare Investments in the Public Sector Will Increase Market Growth
Despite Brazilian economic and industry challenges, the market for reagent kits in in vitro diagnosis (IVD) is experiencing robust growth. This research service leverages primary research that includes several companies manufacturing and marketing reagent kits in IVD, companies distributing or buying these products, and IVD experts, as well as seco...
$6,950.00 -
11 Dec 2013  |  Global  |  Market Research
Analysis of the US Retinal Therapeutics Market
Improvements in Administration and Efficacy Drive Growth
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
$4,950.00 -
03 Dec 2013  |  North America  |  Market Research
Analysis of the Global Tissue Diagnostics Market
Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories
This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...
$10,000.00